FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

FDA Weighs Black Box Warning on Covid Vaccines

FDA considers adding a Boxed Warning to Covid-19 vaccines, the latest action as part of an ongoing campaign to scrutinize and restrict use of the vacc...

latest-news-card-1
Biologics

Amgens Uplizna OKd for Generalized Myasthenia Gravis

FDA approves Amgens Uplizna (inebilizumab-cdon) for adults with generalized myasthenia gravis who test positive for anti-acetylcholine receptor or ant...

latest-news-card-1
Human Drugs

FDA Gives Expedited Review for Lilly Obesity Pill

Senior FDA officials urge agency reviewers to speed up the review of Eli Lillys NDA for its oral weight loss pill orforglipron after the drugmaker pus...

latest-news-card-1
Human Drugs

Study Warns Drug Trials are Lacking Diversity

A new analysis from University of California (UC) Riverside and UC Irvine researchers finds that the vast majority of pivotal clinical trials used to ...

latest-news-card-1
Human Drugs

FDA, Industry Debate America First User Fee Incentive

FDA and drug-industry negotiators exchange early feedback on the agencys proposed America First fee incentives for domestic drug development during a ...

latest-news-card-1
Human Drugs

FDA OKs Akeega for BRCA2-Mutated Metastatic Prostate Cancer

FDA approves Janssens Akeega a fixed-dose combination of niraparib and abiraterone acetate with prednisone for adults with metastatic castration-sen...

latest-news-card-1
Human Drugs

2 Observations on Astellas Pharma FDA-483

FDA releases the form FDA-483 with two observations from an inspection at the Astellas Pharma sterile drug manufacturing facility in Takaoka, Toyama, ...

latest-news-card-1
Human Drugs

Lillys Triple-Agonist Cuts Weight by Nearly 29%

Eli Lillys investigational triple-agonist retatrutide shows substantial weight loss and meaningful reductions in knee osteoarthritis pain in a pivotal...

Medical Devices

Healthcare Opposition to Cybersecurity Reg Change

Cardiovascular Business reports that the American College of Cardiology has joined numerous other healthcare organizations in asking HHS to withdraw a...

latest-news-card-1
Biologics

OpdivoAVD Priority Review for Hodgkin Lymphoma

FDA accepts for priority review a Bristol Myers Squibb supplemental BLA for Opdivo (nivolumab) and its use in combination with AVD chemotherapy for ad...